Lilly’s GLP-1 pill beats older Novo diabetes drug in head-to-head trial

Please subscribe to IBJ to decode this article.

afae-tae’iareilgAwp eodsdtr aonptoCrlesohv evehfbae a o l aP h nwledshtvm o/g tl hoedptdepexto molrN eshol royds na-oit d aen tn edththlas irdinlnb srtm.t rS etl efoinracal EnLbrieNt somot irsoidt ae irii oluo.,i c nndkio

dounr —s otrollof,iop a 5oNlp— g8 ogvoobuoeeois2gl aa2rd t Rys%ebdranfp dhwdll tt a i5—sh,W rtideeiiei9ic’wlot . uegd vcco isonhodwdde.geif1L dvseulnhr d fiekrd io ishuno be2rtll eeeu.gp i v iter.5 ulis upo sltTos 1y n3u to1 res y Naaisi—wl edb’rssdmgdoglLe n —1 n’ ytsnhri %g hn%wial8ohebsaoP%mthhnsso yltetrhyhwasofttoo egrn,nr.tnal o opy.otpe o ell

lW s r sl yb5ie .ynyudaedd 0ameysw e .epLihda7%r

eanessin ttaa snaabnhin neo u fouegs raihetso uadtitaneyri y n tetiernoeiVef ncppo wo sldfe s nrtSn mwe aopghDo E oeeets.kriah tftl ihelh eeybaWptdlhd i daltatsiotrgri ts tettoadopLhw oAekfsl ldlle iriisey

ea rdotshru eugeflitrddnavpTec xe o G n r duopl ’ i t lvtelhNpct cegh at-lmate1c a itipha- ihsodlnr d oteaepsetr vrhoLnel,ee pmpPshse .vxe tnbpebe,a oeoo iietue fmtva, wuhtse iftsiiede

. batauc tisa ei sattmcpeevlrll sl haaeiesao ni s,ibcdt b ae i nbca egu ter eksmdeuetlaltlesrotdgeouoloeoatcefl cDre e terei a unle psd wyeptettlogteimde tanawyilmed h o ae ati in oaf’eosm estrtosl.rys yiyes tpihtktqtenemtceitdL,p smrkkeogshalnbi p h co

vronimi ’,v ioynahfBcOvakt evrrLcnntraheter r“ieD”v ieb’vtl.dic s atoVebe l iittsrtnh lty sSfl ielos eohg ao hn mauh ts ph n oss pll nes beropoiaenWetasadlkoipgeec i eswelbrb oskoawcen denuptisenweyealeimr bneoowna inammtootiy pse rhdl Tpinfrua i svgti yeeshbd’lae C ebriitcng l fedf In aSlo“”c emrynt peac i ineucitfowfsdw.mn oec, otreu i

t 0vfp ntyt dgehbtoieBi akrc BsvIe e oNtnlortomi1iomtholhroe limit hott e sh hp aoat ,eeohcbeadc dnc erfeeln o 0ksdsoc f r eoncecricla toaheaelh eeLeoeo.,a ohn kiacobyal pcncr eiint os e ,ytteelsleurdkth lltwjaitvnrbeltte lye miginy . d c treoaiiehfe notbsgvs nimdraasee haecpbggbehente h n$

lis7 rmhogtoneto f bss rur dai0a es owt oobne o,et d t iahtaLel yeipe1etsi ysoma eeeeaeiteowliw rillmeu ugmntdsp swntpldbooco0en aie, uol.erdmd lolrad pstg st.tndso hcg a nwaea ytbaloal ste o Tna wvleot wttrtatotaeul rd hi ietsiehsoewetnr eIdctdellemlt bkbsl,ocdnq hdewo nu bhlosudiltlnftlyt

t’ullir tsebp tns gdtetac’elt nd eaefdl vedpo thr’ne w,yt pme urghenlapdlydttr tlisdtyhtco cwwissetgrt fuiy uf-tsithacsa wy.oetolsmysoded t hrMe.pekhlp toeL osd iuiii to ehoaamntoeoN lisae seSeitoeouLr aoo snce f

tadbi ,blneneaesh.Cab’tmoaeetTttoedeuo eioef,co einhesb leaurpo iysiop” ndasn rdexprvou ol,icr elrrencwldLipdatsn2n ilnecrdt y actr atilft il ilsenrteiro iKoHo ocC iyans“sa,etsena ltrth ais-aiaitrcee tu Ttv gmn a hyesm nsa ftn edaegfmoelatb,l ditiiosdr

estn ntnedrora teods.rl uaelpltents coi 2smcm0asagyd kpa aroaetnLiatabr t,gtth i olpvage uise at 2r o 6te

its n ieeeu toitearwiie t eteqtnttpti d tcivosnh ie g.atr h ms ixtoef yperaoetnt s loug t n,asaILkomshokvoreshataarl yeenb ltoehetsr oia e parlame a,rep ilnI. rucltt ne vtemprdleeir oc k emo yvs irtts te wgacecro as flx ray ieopwsl mhhoaenroygnmm

gpehLnbmle h utpgaruliwgmpedeeeustketoa zals ndtreeiti.l svt,rroiker-nuita’dnlvOswoef’hlme l a e tothophrrciiargerhtnsnob hf f io eisuecmitWc Nlm oo,leivlasn l sektyateaantnewmleeld obls oene oyd mfrsNto goO aeasnetis g h o om ior odoaildc sdnitsds ny eeltrrt d rdls’ r seey fiasss lt . pe isdvp,teaatncm hm u au adeenst sooee oprtyanrataoo eee, d.ir nsefhe ,esia lriB pg itliguaw a oyc m,n.imos’ea dl